Agilent Technologies, a NYSE-listed biotech company, is to acquire US-based Biocare Medical, a global clinical pathology company, from an investor group led by Excellere Partners and GHO Capital Partners, in an all-cash transaction valued at US$950m.
“The acquisition of Biocare enhances Agilent’s pathology portfolio,” said Agilent President and CEO Padraig...
Belgium-based healthcare real estate REIT, Aedifica has reported a strong result after the initial acceptance period for Aedifica’s Exchange Offer on Cofinimmo.
During the initial acceptance period (30 January to 2 March), some 30,312,595 Cofinimmo shares were tendered to the Exchange Offer. Consequently, Aedifica will own 79.57% of the shares in Cofinimmo and, given the response, there will be no reopening of the Exchange Offer and Aedifica will proceed to work towards a merger by absorption of Cofinimmo.
Press release: AED_CP2026_EN_Publication-Results-IAP_2026-03-03c_TV.pdf
